CardioGenics Holdings Inc. (CGNH)

[tk2007]

They didn't file Q1, now Q2 too ... or they're going dark soon ... these prices are so cheap, but they need to update shareholders ...

[02opida]

Late Q coming

[02opida]

news soon > CGNH

[pontiyak]

Um...forgot to mention an existing revenue stream..

DUH...

yak

[pontiyak]

About Plasticap...A 30 year old company....

http://plasticap.com/

Looks like CGNH wants to do some of the manufacturing of the analyzer in house. What better way than to buy up an existing
plastic component manufacturer.

Smart move IMHO

yak

[02opida]

Time to add > CGNH

[02opida]

CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care? analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it, and its newly created Canadian subsidiary, have entered into a definitive asset purchase agreement to acquire substantially all of the assets of Plasticap. CardioGenics previously announced on October 5, 2015 that it had entered into a binding letter of intent to acquire substantially all of Plasticap's assets.

[tk2007]

These prices are very cheap. It was 10x these prices 6 months ago.

[SIGNATURE23]

I'm hoping for any updates from CGNH. I like what they're involved with.

[02opida]

waiting for the Q > could have something interesting on

[02opida]

q to be late

[02opida]

http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=cgnh&insttype=&freq=1&show=&time=8

[02opida]

.0088 good entry

[pontiyak]

webmoney is here because I am here....

ignore him. He knows nothing of this company or it's history.

yak

[hoppi]

CGNH WILL HAVE A 2000 PERCENT INCREASE IN PRICE DURING 2016. WEBMONEY KNOWS ABSOLUTELY NOTHING ABOUT WHAT IS CURRENTLY HAPPENING AT THE COMPANY!!

[webmoney]

LOL still at it yea!

[temp1]

CardioGenics Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap
Marketwired CardioGenics Holdings Inc.
8 hours ago
????

Related Quotes
CGNH
0.0387
-19.37%
CardioGenics Holdings Inc? Watchlist
0.0387-0.0093(19.37%)
OTC MarketsWed, Nov 4, 2015 3:56 PM EST

CARDIOGENICS HOLDINGS INC. Files SEC form 8-K, Other Events EDGAR Online 16 days ago
CARDIOGENICS HOLDINGS INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online 1 mth 0 days ago
More
MISSISSAUGA, ON--(Marketwired - Nov 4, 2015) - CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it, and its newly created Canadian subsidiary, have entered into a definitive asset purchase agreement to acquire substantially all of the assets of Plasticap. CardioGenics previously announced on October 5, 2015 that it had entered into a binding letter of intent to acquire substantially all of Plasticap's assets.

The asset purchase agreement covers all assets of Plasticap as well as all current and future contracts. The acquisition of two related real property locations that are part of the overall acquisition will close in separate transactions, which are currently being finalized by the parties.

In addition to maintaining Plasticap's ongoing business and blue chip clients, the company intends to utilize Plasticap's expertise in plastics manufacturing to manufacture the company's proprietary self-metering cartridge for its QL Care™ Analyzer, as well as extend Plasticap's reach in the healthcare plastic business.

A Current Report on Form 8-K containing further details regarding the asset purchase agreement and the acquisition of the Plasticap assets will be filed by the company and will be available on EDGAR.

ABOUT PLASTICAP

Plasticap has been in operation for more than 50 years, having started in 1963 operating out of a single facility in Richmond Hill, Ontario. Plasticap has expanded its product line from only aerosol closures to liquor closures and lined plastic closures. Today, Plasticap is a manufacturer of specialty caps and closures for a number of vertical markets, including Food, Dairy, Beverages, Condiments, Industrial, Petro-Chemical, Medical and Pharmaceutical and a critical supply chain partner to many corporations.

Plasticap is expanding its offerings and has developed a new quick load tamper evident valve seal closure to increase filling line speeds by up to 50%. In addition, recent advancements in induction seal CT closures have made it possible to offer attractive logo branding as well as counterfeit security features.

ABOUT CARDIOGENICS HOLDINGS INC.
Through its operating subsidiaries, the Company develops ultra-sensitive analyzers and other products targeting the immunoassay segment of the IVD testing market. It has developed the QL Care™ Analyzer, a proprietary and ultra-sensitive Point-Of-Care immunoanalyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental component of immunoassay equipment), which improve instrument sensitivity to light. The Company's proprietary microspheres technology and SAVASpheres™ magnetic beads are developed and marketed through the Company's LuXSpheres subsidiary. The Company's principal offices are located in Mississauga, Ontario, Canada. For more information please visit www.cardiogenics.com and www.luxspheres.com.

[temp1]

CardioGenics Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap
Marketwired CardioGenics Holdings Inc.
October 5, 2015 9:00 AM
????

MISSISSAUGA, ON--(Marketwired - Oct 5, 2015) - CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it has entered into a binding letter of intent to acquire substantially all of the assets of Plasticap ("LOI). CardioGenics previously announced on August 25, 2015 that it had entered into a manufacturing agreement with Plasticap, pursuant to which Plasticap will manufacture CardioGenics' proprietary self-metering cartridges for its QL Care™ analyzer.

The Purchase Price to be paid by CardioGenics for the Plasticap assets includes the issuance by CardioGenics of preferred stock, common stock and warrants to purchase CardioGenics common stock, as well as the assumption of certain debt instruments of Plasticap, the details of which are set forth in the LOI.

CardioGenics also has engaged AFI Limited of Ontario, Canada to assist in raising short-term capital for CardioGenics.

"We are looking forward to completing our transaction with CardioGenics and becoming part of the CardioGenics team," stated Tom Lato, President of Plasticap. "Plasticap's precision manufacturing capabilities will allow CardioGenics to manufacture its proprietary self-metering cartridge in-house thereby maintaining greater quality control and cost efficiencies in the manufacturing process," continued Mr. Lato.

The parties are currently finalizing the due diligence process. The LOI is subject to the parties entering into definitive agreements for the acquisition. If the parties have not entered into definitive agreements for the acquisition by October 15, 2015, either party my, by written notice to the other, terminate the LOI.

A Current Report on Form 8-K containing further details regarding the LOI and our proposed acquisition of the Plasticap assets will be filed by the company and will be available on EDGAR.

Related Quotes
CGNH
0.0455
+3.41%
CardioGenics Holdings Inc? Watchlist
0.0455+0.0015(3.41%)
OTC MarketsTue, Oct 6, 2015 3:59 PM EDT

CARDIOGENICS HOLDINGS INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online 1 day 11 hrs ago
CARDIOGENICS HOLDINGS INC. Financials EDGAR Online Financials 7 days ago
More
ABOUT PLASTICAP

Plasticap has been in operation for more than 50 years, having started in 1963 operating out of a single facility in Richmond Hill, Ontario. Plasticap has expanded its product line from only aerosol closures to liquor closures and lined plastic closures. Today, Plasticap is a manufacturer of specialty caps and closures for a number of vertical markets, including Food, Dairy, Beverages, Condiments, Industrial, Petro-Chemical, Medical and Pharmaceutical and a critical supply chain partner to many corporations.

Plasticap is expanding its offerings and has developed a new quick load tamper evident valve seal closure to increase filling line speeds by up to 50%. In addition, recent advancements in induction seal CT closures have made it possible to offer attractive logo branding as well as counterfeit security features.

ABOUT CARDIOGENICS HOLDINGS INC.
Through its operating subsidiaries, the Company develops ultra-sensitive analyzers and other products targeting the immunoassay segment of the IVD testing market. It has developed the QL Care™ Analyzer, a proprietary and ultra-sensitive Point-Of-Care immunoanalyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental component of immunoassay equipment), which improve instrument sensitivity to light. The Company's proprietary microspheres technology and SAVASpheres™ magnetic beads are developed and marketed through the Company's LuXSpheres subsidiary. The Company's principal offices are located in Mississauga, Ontario, Canada. For more information please visit www.cardiogenics.com and www.luxspheres.com.

[pontiyak]

I've been following this stock since it was JagNotes.

[Hedge Starz]

Are you in this one?

[pontiyak]

I was wondering when we might hear something from CGNH.

Manufacturing of the cartridge is a good sign, in that it means the QL Care Analyzer works and is being manufactured as well.

But this company sure is quiet...

yak

[temp1]

MISSISSAUGA, Ontario - August 25, 2015 -- CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics ("IVD") testing market, announced today that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics' proprietary self-metering cartridges for its QL Care™ analyzer. The term of the agreement is 3 years and the purchase price for each cartridge shall be as specified in each purchase order issued pursuant to the agreement.

CardioGenics' self-metering cartridge is a disposable pre-loaded test cartridge that allows the QL Care™ analyzer to analyze blood samples without the need for an independent metering mechanism, as the cartridge automatically deposits an accurate amount of whole blood necessary for each test into the cartridge's reaction chamber. This allows the QL Care™ analyzer to provide at the point-of-care quantitative test results of laboratory quality. Point-of-care analyzers that do not utilize self-metering cartridges must instead utilize manual metering of the blood samples, or rely on passive fluid movements, both of which are time-consuming, sometimes inaccurate and add to testing costs.

The self-metering cartridge will be used for all tests on the QL Care™ analyzer, including the Company's upcoming Troponin-I test, which addresses a $600+ million testing market, as well as the Company's planned heart failure tests, which address a $1+ billion testing market.

Dr. Yahia Gawad, Chief Executive Officer of CardioGenics, commented, "We are very pleased that Plasticap will be a manufacturer of the self-metering cartridge for our QL Care™ analyzer. Plasticap has excellent precision manufacturing capabilities and we look forward to working with them."

[Hedge Starz]

Looks like they financing at .11 rather recent as well. I like that.

[Hedge Starz]

Cheap market cap here under 300k I think? Or 500k at least. Very interesting

[Hedge Starz]

Anyone been buying this?

[Hedge Starz]

PR out here

[pontiyak]

and your here to save us ..right ?

Go away..

yak

[-Awaken-]

dump dump dump your boat heavily down the stream. merrily merrily merrily merrily CGNH is a pos with no steammmmmmmmmm. canadian trash should have an F on the end of it

[-Awaken-]

POS. this is why i know to avoid canadian run stocks. always turn shit, just have to give them enough time

[-Awaken-]

Don't ask me, lol...seems it's been dragged down ever since good news, and needs another update to freshen things up again. Just holding/not adding anymore, certainly not happy with the way it looks but someone has taken in big blocks a lot higher and all the way down, maybe they are just waiting for the seller to show their face before they start hitting him rather than putting themselves out there on the bid and letting him whack at a "premium" even though we're down by more than 50% from the highs above .07

[trader08]

0 trades , What happened ?
Also based on the filings I understood that all the debentures are being held by company insiders which is usually a very good thing because they will not crush their own stock , But with all the selling it does look that someone is continuously selling at very low prices and that's not a good sign

[-Awaken-]

rocking the wrong way, still seems to be forming a trend north, but selling needs to stop...might add if it goes 02

[Roy London]

This is going to rock this week... Chart is explosive!

[pontiyak]

It's been a long road. Maybe now with patents in hand CGNH can start to move.

yak

[Roy London]

CGNH BREAKOUT CITY ...going to 10 cents...insiders in at 10 cents

[tk2007]

Agree. Very Undervalued here. Mkt Cap is under $3mil. Partnered with Merck and 2 others. Got Patent.
This is a gem.

[trader08]

This has the potential to be a explosive stock. Definitely risky but looks very promising, Buying now and will see what happens.

[tk2007]

Great day today. Up 70%

[pontiyak]

He acquired just over 2 million shares on Feb 5th/2014, and disposed of approx. 1.9 million the same day.
for a return of $200,000.
Sales price .11/ea.
They were a mix of convertible A & B class debenture shares.

So basically he was converting some shares he was owed from the company into cash.

Obviously he either loaned the company money from before or he is paying himself a salary.

I'm not saying he didn't deserve it, but it's dilution, and
what has CGNH done for us lately ??

I've both owned and followed this company since the early days of JagNotes, and it's been over 5 years.

yak

[tk2007]

CEO, CFO, Director bought bunch of them. Filings out today

[m0n]

What's the date from the 8k on selling??

[pontiyak]

I don't know why... The CEO just dumped a ton of shares for a quick $200,000

yak

[tk2007]

up 86%

[toobigtojail]

when the stock price is .02 and you need to raise money because there is NO revenue = DILUTION.

[pontiyak]

8K out.. looks like some dilution coming..nutz.

yak

[Pennybuster]

$CGNH On Watch Here .0319.

[Roy London]

nice come back

[Roy London]

something is up...asking .061 now...cross that middle bollie and boom time

[DJPennyTrader]

Nice chart... also 525k BUYS to 44k SELLS.... something cooking here IMO

[Roy London]

CGNH beasting $$$$$$$$$$$$$